Lars Olaf Cardell
11 – 20 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Substance P represents a novel first-line defense mechanism in the nose
(
- Contribution to journal › Article
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Letter
- 2017
-
Mark
Genetic variation of the Toll-like receptors in a Swedish allergic rhinitis case population
(
- Contribution to journal › Article
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
(
- Contribution to journal › Scientific review
-
Mark
Chronic rhinosinusitis patients show accumulation of genetic variants in PARS2
(
- Contribution to journal › Article
- 2014
-
Mark
Functional Effects of Toll-Like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 Stimulation in Nasal Epithelial Cells.
(
- Contribution to journal › Article
-
Mark
LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal allergic rhinitis.
(
- Contribution to journal › Article
-
Mark
Haemophilus influenzae reside in tonsills and use IgD binding as an evasion strategy.
(
- Contribution to journal › Article
- 2013
-
Mark
Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis
(
- Contribution to journal › Article